A novel mutation of the calcium-sensing receptor gene in a german subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: The coexistence of familial hypocalciuric hypercalcemia (FHH) and primary hyperparathyroidism (PHPT) is extremely rare. Genetic evidence has demonstrated a causal relationship between FHH and the presence of inactivating mutations in the calcium-sensing receptor gene. Method: We herein report a 60-year-old German patient who was referred for hypercalcemia and increased PTH levels found incidentally during normal routine blood tests. Results: The patient underwent surgical exploration and the diagnosis of PHPT was histologically confirmed. One week later, the follow-up blood tests revealed recurrent hypercalcemia, and the possibility of FHH was reconsidered. Genetic analysis was performed and revealed a novel heterozygous CaSR single missense mutation (Arg551Gly) within the extracellular CaSR domain. Conclusion: We report a novel heterozygous missense inactivating mutation within the extracellular CaSR domain in a German subject with FHH and histologically proven PHPT.

Cite

CITATION STYLE

APA

Papadakis, M., Meurer, N., Margariti, T., Meyer, A., Weyerbrock, N., & Dotzenrath, C. (2016). A novel mutation of the calcium-sensing receptor gene in a german subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Hormones, 15(4), 557–559. https://doi.org/10.14310/horm.2002.1711

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free